ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,151Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 252

$407K Total Retail Price of All Prescriptions

Rank: 127 out of 252

354 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 354 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

16% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,537 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 391 376 1 1
AMLODIPINE BESYLATE 383 365 2 4
FUROSEMIDE 314 297 3 7
POTASSIUM CHLORIDE 274 249 4 8
GABAPENTIN 261 237 5 11
LISINOPRIL 247 215 6 3
HYDROCODONE-ACETAMINOPHEN 246 216 S3 7 5
NAMENDA 210 210 8 41
OMEPRAZOLE 197 189 9 6
DONEPEZIL HCL 155 155 10 28
SIMVASTATIN 147 144 11 2
QUETIAPINE FUMARATE 145 145 12 77
WARFARIN SODIUM 143 120 13 14
CITALOPRAM HBR 141 128 14 15
METOPROLOL TARTRATE 137 132 15 10
CARVEDILOL 129 125 16 22
MIRTAZAPINE 128 128 17 58
ISOSORBIDE MONONITRATE ER 113 110 18 50
SERTRALINE HCL 105 91 19 27
CYMBALTA 104 95 20 45
DOXYCYCLINE HYCLATE 96 88 21 92
AMOX TR-POTASSIUM CLAVULANATE 85 79 22 132
FAMOTIDINE 83 83 23 59
PANTOPRAZOLE SODIUM 74 62 24 62
FENTANYL 74 65 S2 24 126
RISPERIDONE 74 60 24 81
DIGOXIN 70 70 27 44
LANTUS 68 67 28 55
ATENOLOL 66 66 29 18
DEXAMETHASONE SODIUM PHOSPHATE 66 63 29 315
MELOXICAM 65 63 31 20
LEVOFLOXACIN 59 53 32 79
ESCITALOPRAM OXALATE 59 55 32 56
HUMULIN R 58 58 34 202
METOPROLOL SUCCINATE 58 53 34 19
CLOPIDOGREL 56 56 36 29
TRAZODONE HCL 55 47 37 31
SEROQUEL 52 52 38 149
CARBIDOPA-LEVODOPA 51 41 39 107
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.